Taken together, this study provides in vivo and in vitro evidence that FMN could alleviate the development of PCOS by repressing inflammation, apoptosis, and oxidative stress through inhibition of the NLRP3 inflammasome. This evidence concerns the gene NLRP3 and polycystic ovary syndrome.